US Patent Issued to INVOX PHARMA on July 1 for "Antibody molecules that bind PD-L1 and CD137" (British Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,672, issued on July 1, was assigned to INVOX PHARMA Ltd. (London).

"Antibody molecules that bind PD-L1 and CD137" was invented by Matthew Lakins (Cambridge, Great Britain), Jose Munoz-Olaya (Cambridge, Great Britain), Francisca Wollerton (Cambridge, Great Britain), Sarah Batey (Cambridge, Great Britain), Mihriban Tuna (Cambridge, Great Britain) and Alexander Koers (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to antibody molecules that bind both PD-L1 and CD 137 and are able to induce agonism of CD137. The antibody molecules comprise a CDR-based binding site for PD-L1, and a CD137 antigen-bin...